摘要:
Various embodiments of the invention provide human secreted proteins (SECP) and polynucleotides which identify and encode SECP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of SECP.
摘要:
Various embodiments of the invention provide human proteins associated with cell growth, differentiation, and death (CGDD) and polynucleotides which identify and encode CGDD. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of CGDD.
摘要:
The invention provides human secreted proteins (SECP) and polynucleotides which identify and encode SECP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of SECP.
摘要:
The invention provides human secreted proteins (SECP) and polynucleotides which identify and encode SECP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of SECP.
摘要:
The invention provides human secreted proteins (SECP) and polynucleotides which identify and encode SECP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of SECP.
摘要:
The invention provides human kinases and phosphatases (KAP) and polnucleotides which identify and encode KAP. The invention also provides expresson vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of KAP.
摘要:
A method includes diluting a bitumen source, such a bitumen froth from a hot water extraction process, with a hydrocarbon diluent such as naphtha, contacting the bitumen with a zone settling aid such as a polyoxyalkylate block polymer, flocculating water and fine solids in the diluted bitumen, separating the flocculated water and fine solids from the solvent-diluted bitumen, and producing dry, clean diluted bitumen. Preferably, the diluted bitumen will have less than 1.0 wt % water, but most preferably less than 0.7 wt % water. The method may further comprise maintaining the diluted bitumen under conditions that avoid the precipitation of asphaltenes from the bitumen, preferably such that the dry, clean diluted bitumen comprises essentially all, such as greater than 96%, of the asphaltene content from the bitumen source. Counter-current flow may be performed in a series of zone settling stages, such as with gravity settling.